In the BioHarmony Drug Report Database
Vumon (teniposide) is a small molecule pharmaceutical. Teniposide was first approved as Vumon on 1992-07-14. It is used to treat lung neoplasms, lymphoid leukemia, and small cell carcinoma in the USA. It is known to target DNA topoisomerase 2-alpha.
Image (chem structure or protein)